Zevaskyn won FDA approval upon Abeona’s second filing of a biologics license application (BLA) for the therapy.

Scientists identified broadly neutralizing antitoxin antibodies in blood from snake venom-exposed hyperimmune donor for ...

Researchers say GlycoCaging may offer a route to rescue promising drug candidates that currently show unacceptable systemic ...

Researchers say that while a new study has implications for neurodegenerative disease research, its more immediate impact ...

Scientists from the Keck School of Medicine at University of Southern California have developed a spectral flow ...

Accurate genomic profiling is essential for clinical decision-making and optimizing treatment recommendations.

Utilizing a filamentous fungus in the gut microbiome may provide a new strategy for treating metabolic dysfunction-associated ...

Thermo Fisher will provide upstream expansion of hMSCs and downstream purification of MSCs and MSC-derived exosomes, and drug ...

Researchers have identified a potential strategy to protect against Alzheimer’s by increasing the clusterin (CLU) protein, ...

A control PNA turned antimicrobial agent may help eliminate F. nucleatum, a gut microbe tied to cancer progression and ...

Merck KGaA said the deal will grow its U.S. presence and expand the reach of SpringWorks’ drugs, including one approved in ...

Siren said proceeds will go toward investigational new drug (IND)-enabling animal studies and clinical-grade production of ...